Navigation Links
Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
Date:5/28/2008

belief and expectations. These statements are not guarantees of future performance and are subject to certain risks and uncertainties that are difficult to predict. Actual results may differ materially from these forward-looking statements because of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing of clinical trials, the Company's ability to develop and commercialize products, its dependence on collaborators for services and revenue, its substantial indebtedness and lease obligations, its changing requirements and costs associated with facilities, intense competition, the uncertainty of patent and intellectual property protection, the Company's dependence on key management and key suppliers, the uncertainty of regulation of products, the impact of future alliances or transactions and other risks described in the Company's filings with the Securities and Exchange Commission. In addition, the Company will continue to face risks related to animal and human testing, to the manufacture of ABthrax and to FDA concurrence that ABthrax meets the requirements of the ABthrax contract. If the Company is unable to meet the product requirements associated with the ABthrax contract, the U.S. government will not be required to reimburse the Company for the costs incurred or to purchase any ABthrax doses, and we will not receive any of the expected revenues relative to ABthrax. Existing and prospective investors are cautioned not to place undue reliance on these forward-looking statements, which speak only as of today's date. Human Genome Sciences undertakes no obligation to update or revise the information contained in this announcement whether as a result of new information, future events or circumstances or otherwise.


'/>"/>
SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
2. St. Jude Finds Dancing Hair Cells Are Key to Humans Acute Hearing
3. Increases in West Nile Virus Replikin Concentrations Precede Increases in the Number of Human Cases
4. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
5. Quantum Immunologics, Inc. and the South Alabama Medical Science Foundation Announce an Early Clinical Evaluation of a Novel Immuno-therapeutic Vaccine for Treating Advanced Human Breast Carcinomas
6. First Human Implant of New Archus Orthopedics Facet Replacement System
7. Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
8. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
9. Data Show SuperGens MP-470 is Safe in Humans
10. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
11. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... , Oct. 30, 2014 /CNW/ - Atlantic Canadians ... agreement reached between Canada,s provinces ... Keon , President of the Canadian Generic Pharmaceutical Association ... the comments while speaking at the Atlantic Summit on ... , which is being hosted by the Public ...
(Date:10/30/2014)... -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX ), ... serving the pharmaceutical, biotechnology, and medical device industries, with ... the United States , today announced the ... Tel Aviv area of Israel.  ... of integrated R&D services to local customers. It will ...
(Date:10/30/2014)... 30, 2014   ViaDerma, Inc. (OTCQB: ... new products to market, has recently released a ... is a topical liquid tetracycline-based antibiotic that uses ... convert oral medication active ingredients into topical drugs. ... aid antibiotic to help prevent skin infection in ...
Breaking Medicine Technology:Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 2Atlantic Canadians to Save $560-Million Through Unprecedented Three-Year Pan-Canadian Agreement on Generic Prescription Medicines 3WuXi AppTec Launches Representative Office in Israel, Forms Strategic Collaboration with Pontifax 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 2ViaDerma, Inc. Lead Product TetraStem Shown Effective in Fighting Staph Infections including MRSA 3
(Date:10/31/2014)... Thousand Oaks, CA (PRWEB) October 31, 2014 ... flat tummy also has amazing health effects for ... were created by a Doctor of Science and ... discovered through his dedication to pelvic floor reeducation ... incidence of urinary incontinence, Diastasis Recti, Prolepses, etc. ...
(Date:10/31/2014)... With all the preparations families carry ... they may overlook one critical area – the potential ... school performance and even behavior. Typical children’s vision screenings ... progressive vision problems, and to address this challenge, Dr. ... initiative: The Awesome Eyes Student Vision Program. , ...
(Date:10/31/2014)... October 31, 2014 Energy Textiles has ... The new gear is now available online, and Energy ... benefits of Celliant infrared-active athletic gear over compression gear. ... another contract has been signed for Under Armour to ... the next eight years. In light of this decision, ...
(Date:10/31/2014)... 2014 (HealthDay News) -- Sleep apnea may make it hard ... parked your car or left your house keys, a small ... apnea showed that this ability -- called spatial memory -- ... sleep, even when other stages of sleep weren,t affected. REM ... typically occur. "We,ve shown for the first time that ...
(Date:10/31/2014)... cost, patients with early stage breast cancer may ... proton therapy versus whole breast irradiation (WBI), according ... MD Anderson Proton Therapy Center. , ... patient characteristics, researchers used Medicare reimbursement codes to ... partial and whole breast irradiation therapies and treatment ...
Breaking Medicine News(10 mins):Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 2Health News:New School Vision Initiative Announced by Dr. Rosenak’s Optical Options; Program Aims to Help Recognize Unseen Vision Problems That Impact School Success 3Health News:Compression Gear--Is There a Better Alternative? 2Health News:Compression Gear--Is There a Better Alternative? 3Health News:Compression Gear--Is There a Better Alternative? 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 2Health News:Proton therapy shown to be less costly than some alternative radiotherapy techniques 3
... pollutants found in the air, report researchers who studied ... in mice have shown exposure to pollutants is more ... the placenta filters out most of the pollutants. These ... ,Researchers collected blood samples from 265 mothers and ...
... study shows that estrogen therapy does not decrease, but ... say researchers //.Previous studies have reported an association between ... ,A placebo-controlled trial of estrogen or estrogen plus progestin ... associated risk for dementia. In the estrogen-only trial, researchers ...
... be able to anticipate seizures in children with epilepsy.The ... study was // licking, often of the face, ... without aggression. In previous studies, owners of seizure-sensitive dogs ... seizures. Some breeds of seizure-alerting canines include Golden ...
... often leaves cancer patients feeling sick and with a number ... the treatment // and all they go through with it ... are taking a new, more targeted approach to delivering chemotherapy. ... deliver chemotherapy right to the tumor and avoid the toxicity ...
... produced mostly in the testicles and cause prostate cancer ... cancer // shrink or grow more slowly. However, hormone ... used when other treatments such as surgery or radiation ... common treatment for prostate cancer significantly increases the risk ...
... treatment proves to be the best option to substantially reduce ... remove part of the affected vein in addition to compression ... ulcers .Surgery did not present any additional benefit in terms ... from 28 percent to 14 percent at one year. ...
Cached Medicine News:
Store microscope slides with ease, speed, efficiency....
... Negafile offers special drawers for just about ... in a microscopy laboratory. Each box is designed ... Very often the advantages of wood over metal ... mahogany acts as a subtle kind of desiccator ...
A prepared Microscope Slide Cataloging and Storage System....
... resistant, plastic covered corrugated boxes interlock ... up to 500 lbs of overhead ... accommodates 2000 slides or 500 tissue ... requirements. Come unassembled boxes require minimal ...
Medicine Products: